Carregant...
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
Free Fatty Acid receptor 4 (FFA4), also known as GPR120, is a G-protein-coupled receptor (GPCR) responsive to long-chain fatty acids that is attracting considerable attention as a potential novel therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). Although no clinical studies ha...
Guardat en:
| Publicat a: | Trends Pharmacol Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Published By Elsevier In Association With The International Union Of Pharmacology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582618/ https://ncbi.nlm.nih.gov/pubmed/28734639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2017.06.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|